Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP  
8.50
+0.04 (+0.47%)
7:57:07 PM EDT: $8.89 +0.39 (+4.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Corbus Pharmaceuticals Holdings Inc Stock, NASDAQ:CRBP

500 River Ridge Drive, 2nd floor, Norwood, Massachusetts 02062
United States of America
Phone: +1.617.963.0100
Number of Employees: 28

Description

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFÃ?Å? expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.